1. Direct NAD+ Administration (SubQ/IM) Has Poor Cellular Uptake #
NAD+ (nicotinamide adenine dinucleotide) is a large, charged molecule that struggles to penetrate cell membranes when injected intramuscularly (IM) or subcutaneously (SubQ). This is due to:
- Polarity and Size: NAD+ is highly hydrophilic, meaning it does not easily cross lipid bilayers
- Extracellular Degradation: Once in circulation, NAD+ is rapidly broken down by ectonucleotidases (CD38 and CD73) into its precursors before cells can absorb it
Scientific Evidence: Camacho-Pereira et al. (2016) demonstrated that CD38 degrades NAD+ within minutes in vivo. Grozio et al. (2013) showed that extracellular NAD+ does not efficiently enter cells and must first be degraded into NMN or NAM before uptake.
2. NMN is a More Efficient Precursor #
Nicotinamide mononucleotide (NMN) is the direct precursor to NAD+ and has a dedicated transporter (Slc12a8) that allows for rapid and efficient uptake into cells.
- Sublingual NMN is absorbed directly into the bloodstream through the oral mucosa, bypassing first-pass metabolism
- Research by Yao et al. (2018) identified Slc12a8 as an NMN transporter, demonstrating direct uptake into cells
- Mills et al. (2016) showed NMN supplementation increased NAD+ levels in muscle and liver within minutes
3. Biofermented NMN is Superior #
Biofermented NMN has higher purity, better stability, and improved bioavailability compared to synthetic versions — mimicking natural biosynthetic pathways for higher intracellular retention.
Conclusion #
- ✅ Better Bioavailability — Sublingual NMN absorbed directly without degradation
- ✅ Efficient Cellular Uptake — Uses Slc12a8 transporters for rapid intracellular conversion
- ✅ Sustained NAD+ Levels — Bypasses CD38 degradation
- ✅ Mitochondrial Support — Proven to enhance ATP production
- ❌ SubQ/IM NAD+ is Inefficient — Rapid degradation and poor cellular permeability
